Programs of three sessions/week have shown optimal results regarding NAFLD resolution marked by an improvement in insulin sensitivity and a reduction in fasting plasma glucose in several RCTs with both aerobic and resistance exercise [82,84,85,88,94,95,96]. The gene discussed is INS; the disease is metabolic dysfunction-associated steatotic liver disease.